Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

e0473 Rapid re-endothelialization and anti-intimal hyperplasia coronary stent system with a novel biomacromolecular prohealing coating

View through CrossRef
Background Rapid healing of endothelium on the coronary stent is a crucial method to prevent late stent thrombosis, a rare but life-threatening complication of drug eluting stents (DES). Here we developed a novel biomacromolecular coating for pro-healing DES and investigated their anti-proliferation as well as re- endothelialisation function. Methods A dual function DES was designed in an asymmetric coating way: a layer-by-layer (LBL) self-assembly polymer of chitosan/heparin (CS/HEP) coated onto aluminal side of stents to accelerate re-endothelialisation and sirolimus onto vessel wall side to inhibit neointimal hyperplasia. Morphological, gene transcript (RT-PCR), endothelial and antithrombotic marker expression analyses were used to evaluate the effects of CS/HEP coating on adhesion, proliferation and differentiation of CD133+ endothelial progenitor cells (EPCs). Finally, the prohealing function as well as impact on coronary stenosis of this stent system were assessed in porcine model. Results CS/HEP coating can significantly promote the adhesion, proliferation and differentiation of EPCs in vitro. CS/HEP upregulated expression of endothelial marker (ie, PECAM-1 and eNOS) and antithrombotic factor (ie, thrombomodulin). Interestingly, CS/HEP also promoted down-regulation of sirtuin-1, a gene related with endothelial cellular senescence. In porcine model, CS/HEP modified sirolimus eluting stent (CH-SES) showed rapid endothelialization superiority to bare metal stent (BMS) and SES, even in 1 week after stent implantation. Through electron microscopy analysis, the arteries treated with CH-SES were mostly fully endothelialized. As for effects on intimal hyperplasia, by angiography, intravascular ultrasound and histomorphometric analysis, there was no significant difference between CH-SES and SES in intimal thickness from 1 month to 3 and 6 months. Generally, SES took at least 3–4 weeks for the endothelial coverage of the stent struts, while the CH -SES only took 1–2 weeks for endothelial repair and kept antiproliferation function as SES. Conclusion This natural chitosan/heparin biomacromolecular self-assembly coating was safe and efficient in stent implanted porcine model. The preliminary results hinted possible molecular basis of CS/HEP for rapid endothelial recovery. Meanwhile, coated with heparin, the CS -SES showed potent anti-coagulation function compared to traditional SES. To sum up, CS -SES may represent a promising self-rapid healing DES system to prevent in stent thrombosis as well as restenosis.
Title: e0473 Rapid re-endothelialization and anti-intimal hyperplasia coronary stent system with a novel biomacromolecular prohealing coating
Description:
Background Rapid healing of endothelium on the coronary stent is a crucial method to prevent late stent thrombosis, a rare but life-threatening complication of drug eluting stents (DES).
Here we developed a novel biomacromolecular coating for pro-healing DES and investigated their anti-proliferation as well as re- endothelialisation function.
Methods A dual function DES was designed in an asymmetric coating way: a layer-by-layer (LBL) self-assembly polymer of chitosan/heparin (CS/HEP) coated onto aluminal side of stents to accelerate re-endothelialisation and sirolimus onto vessel wall side to inhibit neointimal hyperplasia.
Morphological, gene transcript (RT-PCR), endothelial and antithrombotic marker expression analyses were used to evaluate the effects of CS/HEP coating on adhesion, proliferation and differentiation of CD133+ endothelial progenitor cells (EPCs).
Finally, the prohealing function as well as impact on coronary stenosis of this stent system were assessed in porcine model.
Results CS/HEP coating can significantly promote the adhesion, proliferation and differentiation of EPCs in vitro.
CS/HEP upregulated expression of endothelial marker (ie, PECAM-1 and eNOS) and antithrombotic factor (ie, thrombomodulin).
Interestingly, CS/HEP also promoted down-regulation of sirtuin-1, a gene related with endothelial cellular senescence.
In porcine model, CS/HEP modified sirolimus eluting stent (CH-SES) showed rapid endothelialization superiority to bare metal stent (BMS) and SES, even in 1 week after stent implantation.
Through electron microscopy analysis, the arteries treated with CH-SES were mostly fully endothelialized.
As for effects on intimal hyperplasia, by angiography, intravascular ultrasound and histomorphometric analysis, there was no significant difference between CH-SES and SES in intimal thickness from 1 month to 3 and 6 months.
Generally, SES took at least 3–4 weeks for the endothelial coverage of the stent struts, while the CH -SES only took 1–2 weeks for endothelial repair and kept antiproliferation function as SES.
Conclusion This natural chitosan/heparin biomacromolecular self-assembly coating was safe and efficient in stent implanted porcine model.
The preliminary results hinted possible molecular basis of CS/HEP for rapid endothelial recovery.
Meanwhile, coated with heparin, the CS -SES showed potent anti-coagulation function compared to traditional SES.
To sum up, CS -SES may represent a promising self-rapid healing DES system to prevent in stent thrombosis as well as restenosis.

Related Results

Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury
Synergistic Inhibitory Effect of Angiotensin-Converting Enzyme Inhibitor and Heparin on Intimal Hyperplasia After Rat Aorta Injury
The respective efficacies of angiotensin-converting enzyme (ACE) inhibitor and standard heparin were investigated with respect to their inhibitory effects on intimal hyperplasia af...
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. The first percutaneous coronary intervention was performed by Andreas Gruntzig on Septemb...
Development of a Model for Plaque Induction in Rat Carotid Arteries
Development of a Model for Plaque Induction in Rat Carotid Arteries
Abstract Objective Plaque induction through intimal injury using a balloon catheter in small animals and by artificial ligation of the carotid artery in large animals hav...
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Abstract Background: Percutaneous coronary intervention of calcified coronary lesions is fraught with short-term and long-term risks. Judicious use of adjunct intracoronary...
Cell-cultured PDMS vascular model to allow placement of implant devices
Cell-cultured PDMS vascular model to allow placement of implant devices
AbstractBackgroundA stent maintains normal blood flow by expanding a stenotic artery from the inside. Stents currently in clinical use are mechanically sub-optimized and, therefore...

Back to Top